home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops
Search  -  prev / next
 
 

Vendor-CRO-CMO Oversight in the (Biopharma) and Device Industry

 
  October 26, 2018  
     
 
Netzealous LLC DBA - Compliance4All, Online
2018-12-05


Overview:
This webinar is specifically designed for sponsoring biopharma and device companies who are outsourcing.It will help you get to grips with effective Vendors (including CRO,CMO, and other vendors) management used in the biopharma and device industries and your responsibilities as the sponsor.

Areas Covered in the Session:
Setting up vendor oversight
Inspector expectations
Selection of CROs to meet oversight requirements
Ensuring clarity of roles and responsibilities
RFI and RFP
Contractual consideration for oversight
The oversight/quality plan

Who Will Benefit:
Regulatory
Manufacturing
Pharmacovigilance
Compliance
Audit
Quality

Event Fee: One Dial-in One Attendee Price: US$150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com
 
 
Organized by: Event Manager
Invited Speakers:
Speaker Profile:
Dr. Laura Brown , PhD, MBA, Diploma Clinical Sciences, is an independent QA and training consultant in the pharmaceutical industry. She is a managing director with LB Training and Development Ltd., course director for the M.Sc. in Clinical Research, School of Pharmacy at the University of Cardiff, and course director for M.Sc. Regulatory Affairs, TOPRA.
 
Deadline for Abstracts: 2018-12-04
 
Registration: https://www.compliance4all.com/control/w_product/~product_id=502215LIVE?channel=hum-molgen_Dec_2018_SEO
E-mail: support@compliance4All.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.